Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis.

AUTOR(ES)

Dunne, M

RESUMO

Borrelia burgdorferi is the causative agent of Lyme disease. In the mouse model, protection is correlated with the development of antibodies to a major outer surface protein, OspA. In this study, we expressed OspA in an attenuated strain of Salmonella typhimurium and tested the efficacy of the transformed strain in protecting against disease. We show that mice inoculated by gavage developed high titers of anti-OspA antibodies and were protected against an intradermal challenge with the spirochete.

Documentos Relacionados

• Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.
• Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.
• Nucleotide sequence of the ospAB operon of a Borrelia burgdorferi strain expressing OspA but not OspB.
• OspA vaccination of mice with established Borrelia burgdorferi infection alters disease but not infection.
• An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis.